Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Evaluating the Safety and Efficacy of Proellex® in Premenopausal Women With Symptomatic Uterine Fibroids

ClinicalTrials.gov ID: NCT00853567

Public ClinicalTrials.gov record NCT00853567. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 3:52 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Three-Arm, Parallel Design, Placebo-Controlled, Randomized, Double-Blind, Multicenter Study Evaluating the Safety and Efficacy of Proellex® (CDB-4124) in the Treatment of Premenopausal Women With Symptomatic Uterine Fibroids

Study identification

NCT ID
NCT00853567
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Repros Therapeutics Inc.
Industry
Enrollment
71 participants

Conditions and interventions

Interventions

  • Proellex Drug
  • placebo Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 48 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2009
Primary completion
Jul 31, 2009
Completion
Jul 31, 2009
Last update posted
Aug 20, 2014

2009

United States locations

U.S. sites
17
U.S. states
8
U.S. cities
13
Facility City State ZIP Site status
Advanced Clinical Research Institute Anaheim California 92801
Impact Clinical Trials Los Angeles California 90057
National Institute of Clinical Research Los Angeles California 90057
Impact Clinical Trials Los Angeles California 90211
Segal Institute for Clinical Research Miami Florida 33161
Comprehensive Clinical Trials, LLC West Palm Beach Florida 33409
Phoenix Women's Center (eCast0 College Park Georgia 30349
Clinical Trials Select (eCast) Decatur Georgia 30030
Dekalb Gynecology Associates/Legacy Obstetrics & Gynecology (eCast) Decatur Georgia 30035
Medical Network for Education and Research Decatur Georgia 30333
Smith & Hackney (eCast) Morrow Georgia 30260
Bluegrass Clinical Research, Inc. Louisville Kentucky 40291
Central Brooklyn Medical Group (eCast) Brooklyn New York 11205
Rapid Medical Research, Inc. (Elite) Cleveland Ohio 44122
HWC Women's Research Center Englewood Ohio 45322
Chattanooga Medical Research, LLC Chattanooga Tennessee 37404
Center for Women's Medicine Houston Texas 77079

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00853567, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 20, 2014 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00853567 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →